Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database
Author:
Funder
National Center for Advancing Translational Sciences
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
https://link.springer.com/content/pdf/10.1245/s10434-022-12123-w.pdf
Reference34 articles.
1. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19(12):991–1002. https://doi.org/10.1016/j.neo.2017.09.002.
2. Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42. https://doi.org/10.1001/jamaoncol.2017.0589.
3. Alese AOB, Jiang R, Shaib W, et al. High-grade gastrointestinal neuroendocrine carcinoma management and outcomes: a National Cancer Database study. Oncologist. 2020;25(5):e877. https://doi.org/10.1634/theoncologist.2020-0135.
4. Inno A, Bogina G, Turazza M, et al. Neuroendocrine carcinoma of the breast: current evidence and future perspectives. Oncologist. 2016;21(1):28–32. https://doi.org/10.1634/theoncologist.2015-0309.
5. Li CI, Daling JR. Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomark Prev. 2007;16(12):2773–80. https://doi.org/10.1158/1055-9965.EPI-07-0546.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?;Annals of Surgical Oncology;2024-01-25
2. National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial;Breast Cancer Research and Treatment;2023-10-20
3. Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study;Breast Cancer Research and Treatment;2023-08-11
4. Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation;Frontiers in Oncology;2023-05-17
5. 23rd Annual Meeting of the American Society of Breast Surgeons: Back to In-Person Scientific Exploration;Annals of Surgical Oncology;2022-07-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3